Welcome to Medications.com
Youre adding a drug to your cabinet. Login or Signup to complete this action, or Cancel.

Topamax Information

What's inside Topamax

Topamax Active Ingredients: topiramate, details.
Topamax Dosages & Strengths
Strength Format Route Strength Class
Topamax 25 mg tablet oral 1.0 each OTC
Topamax 100 mg tablet oral 1.0 each OTC
Topamax 200 mg tablet oral 1.0 each OTC
Topamax 50 mg tablet oral 1.0 each OTC

Recent Topamax Side Effects

Posted by petrifiedhippy 4 days ago
March 2009 I was given Topamax, told to take 1 pill a day then start on 2 the next week.... I could not get out of bed, ...

Posted by tedieke 16 days ago
I am decreasing my topamax meds now after taking it for 6 horrible months.. topamax? rather call it dopamax.. I took 100 m...

Posted by mikid 16 days ago
I'm a 41 year old female in very good health- other than the obvious migraine problem that I have. I have been on topamax fo...


Topamax in the News

Study Finds IONSYS™, A New Needle-Free System For Management Of ... - Medical News Today (press release)
... CONCERTA® (ADHD), EPREX® (anaemia), SPORANOX® (fungal infections), VELCADE® (multiple myeloma), PARIET® (gastroenterology), TOPAMAX® (epilepsy), ...
Mon Mar 10 03:09:06 -0400 2008

Study finds IONSYS (TM), a New Needle-Free System for Management ... - PR Newswire UK (press release)
... SPORANOX(R) (fungal infections), VELCADE(R) (multiple myeloma), PARIET(R) (gastroenterology), TOPAMAX(R) (epilepsy), REMINYL(R) (Alzheimer's disease), ...
Tue Mar 04 01:06:57 -0500 2008

Benefiting From 2008's Generic Drugs - Motley Fool
Other blockbusters losing their patent protection in 2008 include Johnson & Johnson's (NYSE: JNJ) Topamax, which Barr Labs and Mylan (NYSE: MYL) are set to ...
Thu Feb 28 14:45:19 -0500 2008


Topamax Chemical Information

topiramate - A sulfamate-substituted monosaccharide with anticonvulsant property. Although the mechanism of action has not been fully elucidated, topiramate antagonizes kainate/AMPA subtype of the glutamate receptors, which are ligand-activated cation channels that mediate the fast component of excitatory postsynaptic currents in neurons of the central nervous system. This antagonistic action results in stabilizing hyper-excited neural membranes, inhibiting repetitive neuronal firing, and decreasing propagation of synaptic impulses, thereby impedes seizure occurrences. In addition, this agent augments gamma-aminobenzoic acid (GABA) activity and thereby attenuating GABAnergic inhibitory transmission.




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea